AGIOS PHARMACEUTICALS INC's ticker is AGIO and the CUSIP is 00847X104. A total of 178 filers reported holding AGIOS PHARMACEUTICALS INC in Q1 2021. The put-call ratio across all filers is 0.64 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2022 | $86,000 | +28.4% | 3,061 | +0.2% | 0.00% | – |
Q2 2022 | $67,000 | -20.2% | 3,054 | +4.2% | 0.00% | – |
Q1 2022 | $84,000 | +21.7% | 2,930 | +37.9% | 0.00% | – |
Q4 2021 | $69,000 | -28.9% | 2,125 | +0.6% | 0.00% | – |
Q3 2021 | $97,000 | -32.6% | 2,113 | -19.7% | 0.00% | – |
Q2 2021 | $144,000 | +7100.0% | 2,630 | +5160.0% | 0.00% | – |
Q1 2021 | $2,000 | 0.0% | 50 | 0.0% | 0.00% | – |
Q4 2020 | $2,000 | -98.4% | 50 | -97.9% | 0.00% | – |
Q2 2020 | $125,000 | +71.2% | 2,341 | +12.7% | 0.00% | – |
Q1 2020 | $73,000 | -88.9% | 2,078 | -85.5% | 0.00% | -100.0% |
Q4 2018 | $659,000 | -40.2% | 14,300 | 0.0% | 0.00% | -50.0% |
Q3 2018 | $1,102,000 | -73.3% | 14,300 | -70.9% | 0.00% | -71.4% |
Q2 2018 | $4,134,000 | +77.2% | 49,087 | +72.0% | 0.01% | +75.0% |
Q1 2018 | $2,333,000 | +4.3% | 28,532 | -27.1% | 0.00% | 0.0% |
Q4 2017 | $2,237,000 | -36.3% | 39,136 | -25.7% | 0.00% | -33.3% |
Q3 2017 | $3,514,000 | +131.8% | 52,659 | +78.6% | 0.01% | +100.0% |
Q2 2017 | $1,516,000 | – | 29,480 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Flagship Pioneering Inc. | 965,369 | $56,378,000 | 14.98% |
Casdin Capital, LLC | 237,500 | $13,870,000 | 8.18% |
BB BIOTECH AG | 2,839,528 | $165,828,000 | 5.42% |
Opaleye Management Inc. | 130,000 | $7,592,000 | 3.78% |
Redmile Group, LLC | 902,578 | $52,711,000 | 3.42% |
Clarius Group, LLC | 109,230 | $6,379,000 | 2.63% |
Opus Point Partners Management, LLC | 57,410 | $3,353,000 | 2.49% |
Ghost Tree Capital, LLC | 125,000 | $7,300,000 | 1.36% |
CAPITAL INTERNATIONAL LTD /CA/ | 346,937 | $20,261,000 | 1.32% |
Eventide Asset Management | 300,800 | $17,567,000 | 1.16% |